Laura Biganzoli

9PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 22, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Paolo Manca, Marta Paoli, Francesca Galardi

|Mar 08, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.

Riccardo Scandino, Agostina Nardone, Nicola Casiraghi

|Mar 01, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi

|Apr 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review.

Mattia Garutti, Gaia Griguolo, Andrea Botticelli

|Feb 25, 2022
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.

Giampaolo Bianchini, Grazia Arpino, Laura Biganzoli

|Jul 02, 2021
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.

Samantha Di Donato, Alessia Vignoli, Chiara Biagioni

Pageof 2

Frequent Collaborators

5 joint publications

Luca Malorni

2 joint publications

Giuseppe Curigliano

2 joint publications

Agostina Nardone

2 joint publications

Fabio Puglisi